Tumor Lysis Syndrome Risk May Rise With Use of Bortezomib for MM in Men AJMC, 11 Dec 2020 Therapy with bortezomib (Velcade) for multiple myeloma (MM) may increase the risk of tumor lysis syndrome (TLS) in male patients…